[1] Wei YH, Xu LZ, Shen Q, et al.  Microdialysis: a technique for pharmacokinetic-pharmacodynamic studies of oncological drugs[J]. Curr Pharm Biotechnol, 2009, 10(6): 631-640.   doi: 10.2174/138920109789069288
[2] Guihen E, O'Connor WT.  Current separation and detection methods in microdialysis the drive towards sensitivity and speed[J]. Electrophoresis, 2009, 30(12): 2062-2075.   doi: 10.1002/elps.200900039
[3] Muijs CT, Beukema JC, Pruim J, et al.  A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer[J]. Radiother Oncol, 2010, 97(2): 165-171.   doi: 10.1016/j.radonc.2010.04.024
[4] Yang Y, Hong H, Zhang Y, et al.  Molecular Imaging of Proteases in Cancer[J]. Cancer Growth Metastasis, 2009, 2: 13-27.
[5] Brunner M, Langer O.  Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution[J]. AAPS J, 2006, 8(2): E263-E271.   doi: 10.1007/BF02854896
[6] Kalant H.  Amicrodialysis procedure for extraction and isolation of corticosteroids from peripheral blood plasma[J]. Biochem J, 1958, 69(1): 99-103.   doi: 10.1042/bj0690099
[7] Cheng GW, Hsu KC, Lee CF, et al.  On-line microdialysis coupled with liquid chromatography for biomedical analysis[J]. J Chromatogr Sci, 2009, 47(8): 624-630.   doi: 10.1093/chromsci/47.8.624
[8] Hutchinson PJ, O'Connell MT, Seal A, et al.  A combined microdialysis and FDG-PET study of glucose metabolism in head injury[J]. Acta Neurochir(Wien), 2009, 151(1): 51-61.   doi: 10.1007/s00701-008-0169-1
[9] Sarrafzadeh A, Haux D, Plotkin M, et al.  Bedside microdialysis reflects dysfunction of cerebral energy metabolism in patients with aneurysmal subarachnoid hemorrhage as confirmed by O-15-H2O-PET and 18F-FDG-PET[J]. J Neuroradiol, 2005, 32(5): 348-351.
[10] Noske DP, Peerdeman SM, Comans EF, et al.  Cerebral microdialysis and positron emission tomography after surgery for aneurysmal subarachnoid hemorrhage in grade Ⅰ patients[J]. Surg Neurol, 2005, 64(2): 109-115.   doi: 10.1016/j.surneu.2004.09.036
[11] Kumakura Y, Cumming P.  PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches[J]. Neuroscientist, 2009, 15(6): 635-650.   doi: 10.1177/1073858409338217
[12] Brooks DJ.  Imaging approaches to Parkinson disease[J]. JNuclMed, 2010, 51(4): 596-609.   doi: 10.1177/1073858409338217
[13] Dohmen C, Bosche B, Graf R, et al.  Prediction of malignant course in MCA infarction by PET and microdialysis[J]. Stroke, 2003, 34(9): 2152-2158.   doi: 10.1161/01.STR.0000083624.74929.32
[14] Hutchinson PJ, Gupta AK, Fryer TF, et al.  Correlation between cerebral blood flow, substrate delivery, and metabolism in head injury: A combined microdialysis and triple oxygen positron emission tomography study[J]. J Cereb Blood Flow Metab, 2002, 22(6): 735-745.   doi: 10.1097/00004647-200206000-00012
[15] Schiffer WK, Mirrione MM, Biegon A, et al.  Serial micro PET measures of the metabolic reaction to a microdialysis probe implant[J]. J Neurosci Methods, 2006, 155(2): 272-284.
[16] Yamamoto S, Onoe H, Tsukada H, et al.  Effects of increased endogenous serotonin on the in vivo binding of [11C] DASB to serotonin transporters in conscious monkey brain[J]. Synapse, 2007, 61(9): 724-731.   doi: 10.1002/syn.20422
[17] Virtanen KA, Peltoniemi P, Marjamäki P, et al.  Human adipose tissue glucose uptake determined using [18F]-fluoro-deoxy-glucose [18F] FDG and PET in combination with microdialysis[J]. Diabetologia, 2001, 44(12): 2171-2179.   doi: 10.1007/s001250100026
[18] Virtanen KA, Haaparanta M, Gronroos T, et al.  2-[18F] fluoro-2-deoxy-D-glucose combined with microdialysis can be used for the comparison of tissue glucose metabolism in obese and lean rats[J]. Diabetes Obes Metab, 2002, 4(1): 60-68.
[19] Houston GC, Hume SP, Hirani E, et al.  Temporal characterisation of amphetamine-induced dopamine release assessed with [11C] raclopride in anaesthetised rodents[J]. Synapse, 2004, 51(3): 206-212.   doi: 10.1002/syn.10296
[20] Doudet DJ, Holden TE.  Sequential versus nonsequential measurement of density and affinity of dopamine D(2) receptors with [11C] raclopride: Effect of methamphetamine[J]. J Cereb Blood Flow Metab, 2003, 23(12): 1489-1494.   doi: 10.1097/01.WCB.0000093325.88757.92
[21] Schiffer WK, Volkow ND, Fowler JS, et al.  Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine[J]. Synapse, 2006, 59(4): 243-251.   doi: 10.1002/syn.20235
[22] Tsukada H, Harada N, Ohba H, et al.  Facilitation of dopaminergic neural transmission does not affect [11C] SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-Ⅳ activity through D(1) receptors: PET studies in the conscious monkey brain[J]. Synapse, 2001, 42(4): 258-265.   doi: 10.1002/syn.10013
[23] Tsukada H, Nishiyama S, Kakiuchi T, et al.  Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of (11C) raclopride?: PET studies combined with microdialysis in conscious monkeys[J]. Brain Res, 1999, 841(1-2): 160-169.   doi: 10.1016/S0006-8993(99)01834-X
[24] Hume S, HiraniE, Opacka-Juffry J, et al.  Effect of 5-HT on binding of [11C] WAY 100635 to 5-HT(IA)receptors in ratbrain, assessed using in vivo microdialysis and PET after fenfluramine[J]. Synapse, 2001, 41(2): 150-159.   doi: 10.1002/syn.1069
[25] Peletier L A, Gabrielsson J.  Dynamics of target-mediated drug disposition[J]. Eur J Pharm Sci, 2009, 38(5): 445-464.   doi: 10.1016/j.ejps.2009.09.007
[26] Haaparanta M, Grönroos T, Marjamäki P, et al.  In vivo sampling for pharmacokinetic studies in small experimental animals: A combination of microdialysis, planar chromatography and digital autoradiography[J]. Mol Imaging Biol, 2004, 6(1): 27-33.   doi: 10.1016/j.mibio.2003.12.005
[27] Nakao R, Okada M, Inoue O, et al.  Combining high-performance liquid chromatography-positron detection and on-line microdialysis for animal metabolism study of positron emission tomography probes[J]. J Chromatogr A, 2008, 1203(2): 193-197.   doi: 10.1016/j.chroma.2008.07.049
[28] Lindner KJ, Hartvig P, Tedroff J, et al.  Liquid chromatographic analysis of brain homogenates and microdialysates for the quantification of L-[beta-11C] DOPA and its metabolites for the validation of positron emission tomography studies[J]. J Pharm Biomed Anal, 1995, 13(4-5): 361-367.   doi: 10.1016/0731-7085(95)01291-R
[29] Langer O, Karch R, Müller U, et al.  Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans[J]. J Nucl Med, 2005, 46(11): 1835-1841.